[ Price : $8.95]
Canadian researchers find that 16% of patients in Phase 2 oncology trials receive treatments that are later approved by FDA for th...[ Price : $8.95]
FDA clears an Abanza 510(k) for its WasherCap Mini fixation system for soft tissue repair, including meniscal root repair and ante...[ Price : $8.95]
FDA accepts for review a Regeneron Pharmaceuticals BLA resubmission for odronextamab in relapsed/refractory follicular lymphoma.[ Price : $8.95]
GenBioPro, which manufactures FDA-approved generic mifepristone, says it wants to be added to the list of defendants in a suit see...[ Price : $8.95]
Fresh on the heels of staff disruptions caused by the termination of about 1,000 probationary employees, the Trump administration ...[ Price : $8.95]
Two Hollingsworth attorneys write in a Washington Legal Foundation post about a California federal court decision tossing state cl...[ Price : $8.95]
FDA releases the form FDA-483 with five observations from an inspection at the Janssen vaccine manufacturing facility in Incheon, ...[ Price : $8.95]
Labcorp and AstraZeneca submit line-by-line comments on an FDA draft guidance on clinical investigation protocol deviations.